Langerhans cells in connective tissue diseases

Area of Science:

• Immunodermatology
• Connective Tissue Diseases

Background:

• Langerhans cells (LC) are crucial accessory cells in skin immunity.
• Alterations in LC populations are observed in various skin conditions.
• Their role in connective tissue diseases requires further elucidation.

Purpose of the Study:

• To quantitatively analyze Langerhans cell density in skin biopsies from patients with connective tissue diseases.
• To investigate potential differences in LC populations between various disease manifestations and normal skin.

Main Methods:

• Quantitative analysis of skin biopsies from 20 patients with connective tissue diseases.
• Immunohistochemical staining using ATPase, anti-DR, and anti-OKT6 markers.
• Assessment of LC density in lesional and clinically normal skin.

Main Results:

• Normal LC densities were observed in clinically normal skin of Systemic Lupus Erythematosus (SLE) patients and lesional skin of Discoid Lupus Erythematosus (DLE).
• A significant decrease in ATPase and OKT6 expression (indicating reduced LC) was found in clinically involved skin of scleroderma patients.
• Clinically normal skin from the same scleroderma patients showed largely normal LC density.

Conclusions:

• Perturbations in Langerhans cell populations in connective tissue diseases, particularly scleroderma, appear to be a localized phenomenon.
• The findings do not support a widespread systemic derangement of skin accessory cells in these conditions.
• LC alterations may be secondary to local disease processes rather than a primary systemic defect.